-transparent.png){kind=logo}
Three cases of severe rash associated with the use of atazanavir are described. In all cases, the rash was maculopapular and pruritic. Rash onset occurred eight to 11 days after initiation of therapy, and resolved with atazanavir discontinuation. Clinicians prescribing atazanavir should be aware of this potential adverse effect.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
May 2006,
AIDS (London, England),
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
August 2014,
Kidney international,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
January 2018,
Nederlands tijdschrift voor geneeskunde,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
July 2020,
JAMA dermatology,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
May 2017,
BMJ case reports,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
October 2012,
Australian family physician,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
January 1988,
Medical and pediatric oncology,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
November 1991,
JAMA,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
October 2006,
Ugeskrift for laeger,
Andrew Walkty, and
Dick Smith, and
Bernie Lopko, and
Ken Kasper
April 1991,
Chest,
